No Detail Found!

Prognostic value of the SII Systemic Immune-Inflammation Index a novel biomarker in coronavirus disease 2019 patient's disease progression to fatality

Author(s)
Sajjad Ali Department of Pulmonology, Mardan Medical Complex, Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Ashraf Department of Pulmonology, Mardan Medical Complex, Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Ishtiaq Ahmad Department of Medicine, Mardan Medical Complex,Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Nabi Rahman Department of Pulmonology, Mardan Medical Complex, Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Shah Zeb Department of Pulmonology, Mardan Medical Complex, Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Muhammad Abbas Department of Pulmonology, Mardan Medical Complex, Pro-Gene Diagnostic and Research Laboratory, Mardan, Pakistan
Abstract
Objective: To identify a novel biomarker with high prognostic value SII Systemic Immune-Inflammation Index in the disease progression of COVID-19 patients with its cost effectiveness and less time consuming. Methodology: This cross-sectional study was carried out from November 2021 to February 2022 at the Mardan Medical Complex, Khyber Pakhtunkhwah, Pakistan. The receiver operating characteristic (ROC) curve analysis was used to discover the ideal cut-off values for predictors for disease severity stage, i.e. asymptomatic, mild, moderate, severe, critical, based on their greatest Youden's index. The SII (platelet X neutrophil count/lymphocyte counts) formula was used to compute the systemic immune inflammation index. Results: Of the 311 cases studied, 233 were included; 155 (66.52%) were male and 78 (33.47%) females. Median age was 38 years (IQR: 18 - 79). Patients had a significant increase in various blood parameters, with an increase in SII index between admission and hospitalization. Normal patients had a SII median 398 (IQR: 312 - 567) upon admission, while abnormal patients had a SII median 659 (IQR: 475 - 1540). Throughout hospitalization, SII index of asymptomatic patients median was 684 (IQR: 470 - 933); cut-off value = 358, mild patients median 909 (IQR: 183 1930); cut-off value = 501, moderate patients median = 992 (IQR: 248 - 6099); cut-off value = 903, severe patients median 1063 (IQR: 104 - 5014); cut-off value = 1147, critical patients median 1230 (IQR: 100 8438); cut-off value = 1481. Conclusion: SII was found to be a significant predictor of COVID-19 patients' severity progression to fatality as an independent prognostic factor. SII is being recommended as a low-cost and less timeconsuming blood test for COVID-19 patients.
Publication Details
Page(s) 63-69
DOI DOI not available
Published Journal: Rawal Medical Journal, Volume: 48, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
Severity, COVID-19., SII, Novel biomarker, Prognostic, Fatality
References
Karimi A,Shobeiri P,Kulasinghe A,Rezaei N. Novel,Systemic Inflammation Markers to Predict N. Novel .2021 .. Prognosis. Front Immunol, 22 : 741061.
Merad M,Martin J .2020 .Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol, 20 : 355-62.
Lucas C,Wong P,Klein J,Castro TBR,Silva J,Sundaram M .2020 .Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature, 584(7821) : 463-9.
Zhang Y,Sun Y,Zhang Q .2020 .Prognostic value of the systemic immune-inflammation index in patients with breast cancer: a meta-analysis. Cancer Cell Int, 20 : 224-9.
Wang C,He W,Yuan Y,Zhang Y,Li K,Zou R .2020 .Comparison of the prognostic value of inflammationbased scores in early recurrent hepatocellular carcinoma after hepatectomy. Liver Int, 40 : 229-39.
Russell CD,Parajuli A,Gale HJ,Bulteel NS,Schuetz P,de Jager CPC .2019 .utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J Infect, 78 : 339-48.
-icd- ,- .2022 .. 2022 [cited 11 October, 02012022 : .
Lagunas-Alvarado M,Mijangos-Huesca FJ,TeránGonzález JO .2017 .Systemic immune inflammatory index in sepsis. Med Int Mex, 33 : 303-309.
Ashraf M,Ahmad I,Ali S,Rahman N .2022 .Ali A. Estimation of emerging diagnostic parameters for Coronavirus Disease 2019 patients severity and fatality. J Pak Med Assoc, 72 : 1384-90.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395 : 497-506.
Paliogiannis P,Zinellu A,Scano V .2020 .Laboratory test alterations in patients with COVID-19 and non COVID19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries, 14 : 685-90.
Yang A,Liu J,Tao W,Li H. .2020 .The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients. Int Immunopharmacol, 84 : 106504.
Russell CD,Parajuli A,Gale HJ,Bulteel NS,Schuetz P,de Jager CPC .2019 .The utility of peripheral blood leucocyte ratios as biomarkers in infectious diseases: A systematic review and meta-analysis. J Infect, 78 : 339-48.
Huang C,Wang Y,Li X,Ren L,Zhao J,Hu Y .2020 .Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. , 395(10223) : 497-506.
Naess A,Mo R,Nilssen S,Eide G,Sjursen H. .2013 .Infections in patients hospitalized for fever as related to duration and other predictors at admittance. Infection, 42 : 485-92.
Zhang Y,Zou P,Gao H,Yang M,Yi P,Gan J .2019 .Neutrophil-lymphocyte ratio as an early new marker in AIV-H7N9-infected patients: a retrospective study. Ther Clin Risk Manag, 15 : 911-19.
Sun S,Cai X,Wang H,He G,Lin Y,Lu B .2020 .Abnormalities of peripheral blood system in patients with COVID-. Clin Chim Acta, 507 : 174-80.
Chen L,Yu J,He W,Chen L,Yuan G,Dong F G .2020 .Risk factors for death in 1859 subjects with COVID-19. Leukemia, 34 : 2173-83.
Paliogiannis P,Zinellu A,Scano V,Mulas G,De Riu G,Pascale RM .2020 .Laboratory test alterations in patients with COVID-19 and non COVID-19 interstitial pneumonia: a preliminary report. J Infect Dev Ctries, 14 : 685-90.
Hong X,Cui B,Wang M,Yang Z,Wang L,Xu Q.,Systemic Q.,Index Q.,Neutrophil-Lymphocyte Ratio .2015 .Is Useful for Predicting Prognosis in Small Cell Lung Cancer. Tohoku J Exp Med, 236 : 297-304.
Hu B,Yang X,Xu Y,Sun Y,Sun C,Guo W. Systemic .2014 .Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma. Clin Cancer Res, 20 : 6212-22.
0

Citations

0

Downloads

52

Views